1,958 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 884 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9871,958 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 285234 (-51)

Holders
1,958
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$327M
3 +$270M
4
Renaissance Technologies
Renaissance Technologies
New York
+$231M
5
JP Morgan Chase
JP Morgan Chase
New York
+$176M
Name Holding Trade Value Shares
Change
Change in
Stake
1801
$264K
1802
$263K
1803
$263K
1804
$262K
1805
$261K
1806
$261K
1807
$260K
1808
$259K
1809
$259K
1810
$258K
1811
$257K
1812
$256K
1813
$255K
1814
$254K
1815
$254K
1816
$254K
1817
$253K
1818
$251K
1819
$251K
1820
$251K
1821
$250K
1822
$250K
1823
$250K
1824
$249K
1825
$247K